HOME >> BIOLOGY >> NEWS
New studies on bone marrow failure diseases presented at scientific symposium Oct. 18-19

The latest advances in aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH) and other bone marrow failure diseases will be presented at the Bone Marrow Failure Scientific Symposium Oct. 18-19 in Washington, DC. This is the first international meeting covering all bone marrow diseases--life-threatening conditions for which, in most cases, the cause is unknown.

New research on stem cell transplantation, immunosuppressive treatments, drug therapies and alternative approaches will be presented by the world's leading physicians on bone marrow failure diseases.

The symposium is sponsored by the National Institutes of Health, including the Office of Rare Diseases, the National Heart, Lung and Blood Institute and the National Cancer Institute; and organized by Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF). Co-chairs are Jaroslaw Maciejewski, MD, PhD, Cleveland Clinic Foundation, Taussig Cancer Center and Neal S. Young, MD, National Heart, Lung and Blood Institute.

More information on the symposium is at AA&MDSIF's web site: http://www.aamds.org

What:
Bone Marrow Failure Scientific Symposium

Who:
--National Heart, Lung and Blood Institute
--National Cancer Institute
--Office of Rare Diseases
--Aplastic Anemia & MDS International Foundation, Inc.

When:
Oct. 18-19, 2005

Where:
L'Enfant Plaza Hotel, 480 L'Enfant Plaza, Washington, DC
Press must register for the symposium. Accredited journalists receive complimentary registration.
To register contact: Brian Ruberry, 301-948-1709, br@allhealthpr.com.


'"/>

Contact: Brian Ruberry
br@allhealthpr.com
301-948-1709
Aplastic Anemia & MDS International Foundation
30-Sep-2005


Page: 1

Related biology news :

1. New studies on goats milk show it is more beneficial to health than cows milk
2. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
3. Obtaining valid consent for doing large genetic studies in developing countries
4. Short-term studies suggest that whole grain oats may reduce risk factors for coronary heart disease
5. New studies link the environment to Parkinsons disease
6. Ewwwww! UCLA anthropologist studies evolutions disgusting side
7. Genetic studies endow mice with new color vision
8. Epigenetic studies will provide a better understanding of disease
9. New mathematical model to add rigor to studies of disease genetics and evolution
10. Genes and groups of genes commonly shared between species, studies show
11. New bird, bat species revealed by extensive DNA barcode studies

Post Your Comments:
(Date:8/4/2015)... ) today reported financial and operating results for the second quarter ... quarter contract revenue of $ 85.2 million, a ... of 26 % , Second quarter adjusted ... royalties in the current quarter , Operating cash ... to present another strong financial quarter, with all our divisions achieving ...
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
(Date:8/31/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... scientific review has identified high value opportunities for ... patient need. Novogen is moving as quickly as ... entering into Phase 1 clinical trials with our ... Officer, Iain Ross , said that following ...
(Date:8/31/2015)... ... August 31, 2015 , ... Regulatory agencies have ... drug development approval process. Thus, innovator companies must understand what will be needed ... Chicago-based CMO, has been hosting multiple educational panels and seminars for experts to ...
(Date:8/28/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zsgg5n/global_and_usa ) ... USA BioSimilar Market Analysis to 2021" report to ... market will be initiated in September as Sandoz launches ... global market react? Will biosimilars explode into the biologics ... US economy up to $250 billion within the next ...
(Date:8/28/2015)... ... 2015 , ... Riordan-McKenna Institute founders, stem cell ... the use of sterile, dehydrated amniotic tissue AlphaPATCH™ developed by Amniotic Therapies ... knee wound. , The case involved a 78-year-old male, who presented with a ...
Breaking Biology Technology:Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6Regis Shares Expert Advice on Impurities in Drug Development 2Regis Shares Expert Advice on Impurities in Drug Development 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 2Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 3Dallas-Fort Worth Stem Cell Researchers Use Amniotic Tissue To Successfully Treat Non-Healing Surgical Wound 4
Cached News: